In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


This content is currently on FREE ACCESS, enjoy another 54 days of free consultation

In these unprecedented times, the ESC is doing everything it can to support its community: FREE access to all ESC 365 content until 31 July: explore more than 125,000 educational resources.

From 1 August onwards, support our mission by becoming a member.

Experiences of remote monitoring in recipients of implantable cardioverter defibrillators

Session Moderated poster session - Arrhythmias, Frailty and Advanced Practice

Speaker Maria Liljeroos

Event : EuroHeartCare 2019

  • Topic : arrhythmias and device therapy
  • Sub-topic : Arrhythmias, General - Other
  • Session type : Moderated Posters

Authors : M Liljeroos (Linkoping,SE), A Stromberg (Linkoping,SE)

Authors:
M Liljeroos1 , A Stromberg2 , 1Centre for Clinical Research Sörmland, Uppsala University, Uppsala, and, Division of Nursing Sciences, Department of Medicine and Health Sciences, Linköping University - Linkoping - Sweden , 2Linkoping University, Department of Medical and Health Sciences, Division of Nursing Science - Linkoping - Sweden ,

Citation:

Introduction; Remote patient monitoring (RPM) of Implantable Cardioverter Defibrillator (ICD) with medical information transmitted via telemedia, leads to fewer visits to the device clinics. The RPM is suggested to increase safety and quality of life and decrease the risk of hospitalisation for ICD recipients. However, evaluations of the perspective of ICD recipients on safety, usability, and preferences are scares.

Therefore, the aim of this survey was to explore ICD recipients’ experiences of remote monitoring of the ICD and describe device-related concerns perceived by the patients.

Methods; A survey was sent to all ICD recipients in one county council with a catchment area of 300 000 inhabitants. Starting in 2015, all individuals receiving an ICD in this county council are followed-up remotely. The survey included questionnaires on the experiences of RPM, perceived control, anxiety and depression and device related concerns.

Results; A total of 170 patients (78% men, mean age 70,1 years, 15,5% working) were included in the analysis, response rate 98%. The result showed that almost everyone (99%) had positive experiences of remote monitoring of the ICD, 85% found the technique easy to manage and for 95% the RPM increased security and safety, and 91% answered that RPM increased family members security.

A total of 38% of the ICD recipients scored mild to moderate depressive symptoms. Depressive symptoms were not found to affect the experience regarding RPM, but those with depressive symptoms were significantly more worried about receiving an ICD shock (p<0.015).

Also, those with low perceived control were more worried that the ICD would shock (p<0.034) and that overexertion would cause the ICD to shock (p<0.029).

Conclusions; Persons with an implanted ICDs found RPM easy to manage and that RPM increased the sense of security. Future interventions should focus on targeting the ICD recipients with low level of perceived control over the heart disease and symptoms of depression in order to decrease the level of device-related concerns. Using RPM in combination with assessment and interventions to decrease ICD related concerns and psychological distress are warranted.

This content is currently on FREE ACCESS, enjoy another 54 days of free consultation

In these unprecedented times, the ESC is doing everything it can to support its community: FREE access to all ESC 365 content until 31 July: explore more than 125,000 educational resources.

From 1 August onwards, support our mission by becoming a member.



Based on your interests

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are